Global Vasculitis Treatment Market Growth (Status and Outlook) 2022-2028

As the global economy mends, the 2021 growth of Vasculitis Treatment will have significant change from previous year. According to our (LP Information) latest study, the global Vasculitis Treatment market size is USD  million in 2022 from USD 399.3 million in 2021, with a change of  % between 2021 and 2022. The global Vasculitis Treatment market size will reach USD 521.9 million in 2028, growing at a CAGR of 3.9% over the analysis period.

The United States Vasculitis Treatment market is expected at value of US$  million in 2021 and grow at approximately  % CAGR during review period. China constitutes a  % market for the global Vasculitis Treatment market, reaching US$  million by the year 2028. As for the Europe Vasculitis Treatment landscape, Germany is projected to reach US$  million by 2028 trailing a CAGR of  % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at  % and  % respectively for the next 5-year period.

Global main Vasculitis Treatment players cover Abbvie, Ablynx, Amgen, and Anthera Pharmaceuticals, etc. In terms of revenue, the global largest two companies occupy a share nearly  % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Vasculitis Treatment market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
    Large Vasculitis Treatment
    Medium Vasculitis Treatment
    Small Vasculitis Treatment

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
    Hospitals And Clinics
    Diagnosis Center
    Research Institutes
    Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
    Abbvie
    Ablynx
    Amgen
    Anthera Pharmaceuticals
    Aspen Pharmacare Holdings
    Astrazeneca
    Baxter
    Biogen
    Bristol-Myers Squibb
    Celgene
    Celltrion
    Chemocentryx
    Chugai Pharma Usa
    Eisai
    Eli Lilly
    F. Hoffmann-La Roche
    Genentech
    Gilead
    Glaxosmithkline
    Human Genome Sciences

List of Tables
    Table 1. Vasculitis Treatment Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
    Table 2. Major Players of Large Vasculitis Treatment
    Table 3. Major Players of Medium Vasculitis Treatment
    Table 4. Major Players of Small Vasculitis Treatment
    Table 5. Vasculitis Treatment Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
    Table 6. Global Vasculitis Treatment Market Size by Type (2017-2022) & ($ Millions)
    Table 7. Global Vasculitis Treatment Market Size Market Share by Type (2017-2022)
    Table 8. Vasculitis Treatment Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
    Table 9. Global Vasculitis Treatment Market Size by Application (2017-2022) & ($ Millions)
    Table 10. Global Vasculitis Treatment Market Size Market Share by Application (2017-2022)
    Table 11. Global Vasculitis Treatment Revenue by Players (2020-2022) & ($ Millions)
    Table 12. Global Vasculitis Treatment Revenue Market Share by Player (2020-2022)
    Table 13. Vasculitis Treatment Key Players Head office and Products Offered
    Table 14. Vasculitis Treatment Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    Table 15. New Products and Potential Entrants
    Table 16. Mergers & Acquisitions, Expansion
    Table 17. Global Vasculitis Treatment Market Size by Regions 2017-2022 & ($ Millions)
    Table 18. Global Vasculitis Treatment Market Size Market Share by Regions (2017-2022)
    Table 19. Americas Vasculitis Treatment Market Size by Country (2017-2022) & ($ Millions)
    Table 20. Americas Vasculitis Treatment Market Size Market Share by Country (2017-2022)
    Table 21. Americas Vasculitis Treatment Market Size by Type (2017-2022) & ($ Millions)
    Table 22. Americas Vasculitis Treatment Market Size Market Share by Type (2017-2022)
    Table 23. Americas Vasculitis Treatment Market Size by Application (2017-2022) & ($ Millions)
    Table 24. Americas Vasculitis Treatment Market Size Market Share by Application (2017-2022)
    Table 25. APAC Vasculitis Treatment Market Size by Region (2017-2022) & ($ Millions)
    Table 26. APAC Vasculitis Treatment Market Size Market Share by Region (2017-2022)
    Table 27. APAC Vasculitis Treatment Market Size by Type (2017-2022) & ($ Millions)
    Table 28. APAC Vasculitis Treatment Market Size Market Share by Type (2017-2022)
    Table 29. APAC Vasculitis Treatment Market Size by Application (2017-2022) & ($ Millions)
    Table 30. APAC Vasculitis Treatment Market Size Market Share by Application (2017-2022)
    Table 31. Europe Vasculitis Treatment Market Size by Country (2017-2022) & ($ Millions)
    Table 32. Europe Vasculitis Treatment Market Size Market Share by Country (2017-2022)
    Table 33. Europe Vasculitis Treatment Market Size by Type (2017-2022) & ($ Millions)
    Table 34. Europe Vasculitis Treatment Market Size Market Share by Type (2017-2022)
    Table 35. Europe Vasculitis Treatment Market Size by Application (2017-2022) & ($ Millions)
    Table 36. Europe Vasculitis Treatment Market Size Market Share by Application (2017-2022)
    Table 37. Middle East & Africa Vasculitis Treatment Market Size by Region (2017-2022) & ($ Millions)
    Table 38. Middle East & Africa Vasculitis Treatment Market Size Market Share by Region (2017-2022)
    Table 39. Middle East & Africa Vasculitis Treatment Market Size by Type (2017-2022) & ($ Millions)
    Table 40. Middle East & Africa Vasculitis Treatment Market Size Market Share by Type (2017-2022)
    Table 41. Middle East & Africa Vasculitis Treatment Market Size by Application (2017-2022) & ($ Millions)
    Table 42. Middle East & Africa Vasculitis Treatment Market Size Market Share by Application (2017-2022)
    Table 43. Key Market Drivers & Growth Opportunities of Vasculitis Treatment
    Table 44. Key Market Challenges & Risks of Vasculitis Treatment
    Table 45. Key Industry Trends of Vasculitis Treatment
    Table 46. Global Vasculitis Treatment Market Size Forecast by Regions (2023-2028) & ($ Millions)
    Table 47. Global Vasculitis Treatment Market Size Market Share Forecast by Regions (2023-2028)
    Table 48. Global Vasculitis Treatment Market Size Forecast by Type (2023-2028) & ($ Millions)
    Table 49. Global Vasculitis Treatment Market Size Market Share Forecast by Type (2023-2028)
    Table 50. Global Vasculitis Treatment Market Size Forecast by Application (2023-2028) & ($ Millions)
    Table 51. Global Vasculitis Treatment Market Size Market Share Forecast by Application (2023-2028)
    Table 52. Abbvie Details, Company Type, Vasculitis Treatment Area Served and Its Competitors
    Table 53. Abbvie Vasculitis Treatment Product Offered
    Table 54. Abbvie Vasculitis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 55. Abbvie Main Business
    Table 56. Abbvie Latest Developments
    Table 57. Ablynx Details, Company Type, Vasculitis Treatment Area Served and Its Competitors
    Table 58. Ablynx Vasculitis Treatment Product Offered
    Table 59. Ablynx Main Business
    Table 60. Ablynx Vasculitis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 61. Ablynx Latest Developments
    Table 62. Amgen Details, Company Type, Vasculitis Treatment Area Served and Its Competitors
    Table 63. Amgen Vasculitis Treatment Product Offered
    Table 64. Amgen Main Business
    Table 65. Amgen Vasculitis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 66. Amgen Latest Developments
    Table 67. Anthera Pharmaceuticals Details, Company Type, Vasculitis Treatment Area Served and Its Competitors
    Table 68. Anthera Pharmaceuticals Vasculitis Treatment Product Offered
    Table 69. Anthera Pharmaceuticals Main Business
    Table 70. Anthera Pharmaceuticals Vasculitis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 71. Anthera Pharmaceuticals Latest Developments
    Table 72. Aspen Pharmacare Holdings Details, Company Type, Vasculitis Treatment Area Served and Its Competitors
    Table 73. Aspen Pharmacare Holdings Vasculitis Treatment Product Offered
    Table 74. Aspen Pharmacare Holdings Main Business
    Table 75. Aspen Pharmacare Holdings Vasculitis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 76. Aspen Pharmacare Holdings Latest Developments
    Table 77. Astrazeneca Details, Company Type, Vasculitis Treatment Area Served and Its Competitors
    Table 78. Astrazeneca Vasculitis Treatment Product Offered
    Table 79. Astrazeneca Main Business
    Table 80. Astrazeneca Vasculitis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 81. Astrazeneca Latest Developments
    Table 82. Baxter Details, Company Type, Vasculitis Treatment Area Served and Its Competitors
    Table 83. Baxter Vasculitis Treatment Product Offered
    Table 84. Baxter Main Business
    Table 85. Baxter Vasculitis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 86. Baxter Latest Developments
    Table 87. Biogen Details, Company Type, Vasculitis Treatment Area Served and Its Competitors
    Table 88. Biogen Vasculitis Treatment Product Offered
    Table 89. Biogen Main Business
    Table 90. Biogen Vasculitis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 91. Biogen Latest Developments
    Table 92. Bristol-Myers Squibb Details, Company Type, Vasculitis Treatment Area Served and Its Competitors
    Table 93. Bristol-Myers Squibb Vasculitis Treatment Product Offered
    Table 94. Bristol-Myers Squibb Main Business
    Table 95. Bristol-Myers Squibb Vasculitis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 96. Bristol-Myers Squibb Latest Developments
    Table 97. Celgene Details, Company Type, Vasculitis Treatment Area Served and Its Competitors
    Table 98. Celgene Vasculitis Treatment Product Offered
    Table 99. Celgene Main Business
    Table 100. Celgene Vasculitis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 101. Celgene Latest Developments
    Table 102. Celltrion Details, Company Type, Vasculitis Treatment Area Served and Its Competitors
    Table 103. Celltrion Vasculitis Treatment Product Offered
    Table 104. Celltrion Vasculitis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 105. Celltrion Main Business
    Table 106. Celltrion Latest Developments
    Table 107. Chemocentryx Details, Company Type, Vasculitis Treatment Area Served and Its Competitors
    Table 108. Chemocentryx Vasculitis Treatment Product Offered
    Table 109. Chemocentryx Main Business
    Table 110. Chemocentryx Vasculitis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 111. Chemocentryx Latest Developments
    Table 112. Chugai Pharma Usa Details, Company Type, Vasculitis Treatment Area Served and Its Competitors
    Table 113. Chugai Pharma Usa Vasculitis Treatment Product Offered
    Table 114. Chugai Pharma Usa Main Business
    Table 115. Chugai Pharma Usa Vasculitis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 116. Chugai Pharma Usa Latest Developments
    Table 117. Eisai Details, Company Type, Vasculitis Treatment Area Served and Its Competitors
    Table 118. Eisai Vasculitis Treatment Product Offered
    Table 119. Eisai Main Business
    Table 120. Eisai Vasculitis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 121. Eisai Latest Developments
    Table 122. Eli Lilly Details, Company Type, Vasculitis Treatment Area Served and Its Competitors
    Table 123. Eli Lilly Vasculitis Treatment Product Offered
    Table 124. Eli Lilly Main Business
    Table 125. Eli Lilly Vasculitis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 126. Eli Lilly Latest Developments
    Table 127. F. Hoffmann-La Roche Details, Company Type, Vasculitis Treatment Area Served and Its Competitors
    Table 128. F. Hoffmann-La Roche Vasculitis Treatment Product Offered
    Table 129. F. Hoffmann-La Roche Main Business
    Table 130. F. Hoffmann-La Roche Vasculitis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 131. F. Hoffmann-La Roche Latest Developments
    Table 132. Genentech Details, Company Type, Vasculitis Treatment Area Served and Its Competitors
    Table 133. Genentech Vasculitis Treatment Product Offered
    Table 134. Genentech Main Business
    Table 135. Genentech Vasculitis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 136. Genentech Latest Developments
    Table 137. Gilead Details, Company Type, Vasculitis Treatment Area Served and Its Competitors
    Table 138. Gilead Vasculitis Treatment Product Offered
    Table 139. Gilead Main Business
    Table 140. Gilead Vasculitis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 141. Gilead Latest Developments
    Table 142. Glaxosmithkline Details, Company Type, Vasculitis Treatment Area Served and Its Competitors
    Table 143. Glaxosmithkline Vasculitis Treatment Product Offered
    Table 144. Glaxosmithkline Main Business
    Table 145. Glaxosmithkline Vasculitis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 146. Glaxosmithkline Latest Developments
    Table 147. Human Genome Sciences Details, Company Type, Vasculitis Treatment Area Served and Its Competitors
    Table 148. Human Genome Sciences Vasculitis Treatment Product Offered
    Table 149. Human Genome Sciences Main Business
    Table 150. Human Genome Sciences Vasculitis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 151. Human Genome Sciences Latest Developments
List of Figures
    Figure 1. Vasculitis Treatment Report Years Considered
    Figure 2. Research Objectives
    Figure 3. Research Methodology
    Figure 4. Research Process and Data Source
    Figure 5. Global Vasculitis Treatment Market Size Growth Rate 2017-2028 ($ Millions)
    Figure 6. Global Vasculitis Treatment Market Size Market Share by Type in 2021
    Figure 7. Vasculitis Treatment in Hospitals And Clinics
    Figure 8. Global Vasculitis Treatment Market: Hospitals And Clinics (2017-2022) & ($ Millions)
    Figure 9. Vasculitis Treatment in Diagnosis Center
    Figure 10. Global Vasculitis Treatment Market: Diagnosis Center (2017-2022) & ($ Millions)
    Figure 11. Vasculitis Treatment in Research Institutes
    Figure 12. Global Vasculitis Treatment Market: Research Institutes (2017-2022) & ($ Millions)
    Figure 13. Vasculitis Treatment in Others
    Figure 14. Global Vasculitis Treatment Market: Others (2017-2022) & ($ Millions)
    Figure 15. Global Vasculitis Treatment Market Size Market Share by Application in 2021
    Figure 16. Global Vasculitis Treatment Revenue Market Share by Player in 2021
    Figure 17. Global Vasculitis Treatment Market Size Market Share by Regions (2017-2022)
    Figure 18. Americas Vasculitis Treatment Market Size 2017-2022 ($ Millions)
    Figure 19. APAC Vasculitis Treatment Market Size 2017-2022 ($ Millions)
    Figure 20. Europe Vasculitis Treatment Market Size 2017-2022 ($ Millions)
    Figure 21. Middle East & Africa Vasculitis Treatment Market Size 2017-2022 ($ Millions)
    Figure 22. Americas Vasculitis Treatment Value Market Share by Country in 2021
    Figure 23. Americas Vasculitis Treatment Consumption Market Share by Type in 2021
    Figure 24. Americas Vasculitis Treatment Market Size Market Share by Application in 2021
    Figure 25. United States Vasculitis Treatment Market Size Growth 2017-2022 ($ Millions)
    Figure 26. Canada Vasculitis Treatment Market Size Growth 2017-2022 ($ Millions)
    Figure 27. Mexico Vasculitis Treatment Market Size Growth 2017-2022 ($ Millions)
    Figure 28. Brazil Vasculitis Treatment Market Size Growth 2017-2022 ($ Millions)
    Figure 29. APAC Vasculitis Treatment Market Size Market Share by Region in 2021
    Figure 30. APAC Vasculitis Treatment Market Size Market Share by Application in 2021
    Figure 31. China Vasculitis Treatment Market Size Growth 2017-2022 ($ Millions)
    Figure 32. Japan Vasculitis Treatment Market Size Growth 2017-2022 ($ Millions)
    Figure 33. Korea Vasculitis Treatment Market Size Growth 2017-2022 ($ Millions)
    Figure 34. Southeast Asia Vasculitis Treatment Market Size Growth 2017-2022 ($ Millions)
    Figure 35. India Vasculitis Treatment Market Size Growth 2017-2022 ($ Millions)
    Figure 36. Australia Vasculitis Treatment Market Size Growth 2017-2022 ($ Millions)
    Figure 37. Europe Vasculitis Treatment Market Size Market Share by Country in 2021
    Figure 38. Europe Vasculitis Treatment Market Size Market Share by Type in 2021
    Figure 39. Europe Vasculitis Treatment Market Size Market Share by Application in 2021
    Figure 40. Germany Vasculitis Treatment Market Size Growth 2017-2022 ($ Millions)
    Figure 41. France Vasculitis Treatment Market Size Growth 2017-2022 ($ Millions)
    Figure 42. UK Vasculitis Treatment Market Size Growth 2017-2022 ($ Millions)
    Figure 43. Italy Vasculitis Treatment Market Size Growth 2017-2022 ($ Millions)
    Figure 44. Russia Vasculitis Treatment Market Size Growth 2017-2022 ($ Millions)
    Figure 45. Middle East & Africa Vasculitis Treatment Market Size Market Share by Region in 2021
    Figure 46. Middle East & Africa Vasculitis Treatment Market Size Market Share by Type in 2021
    Figure 47. Middle East & Africa Vasculitis Treatment Market Size Market Share by Application in 2021
    Figure 48. Egypt Vasculitis Treatment Market Size Growth 2017-2022 ($ Millions)
    Figure 49. South Africa Vasculitis Treatment Market Size Growth 2017-2022 ($ Millions)
    Figure 50. Israel Vasculitis Treatment Market Size Growth 2017-2022 ($ Millions)
    Figure 51. Turkey Vasculitis Treatment Market Size Growth 2017-2022 ($ Millions)
    Figure 52. GCC Country Vasculitis Treatment Market Size Growth 2017-2022 ($ Millions)
    Figure 53. Americas Vasculitis Treatment Market Size 2023-2028 ($ Millions)
    Figure 54. APAC Vasculitis Treatment Market Size 2023-2028 ($ Millions)
    Figure 55. Europe Vasculitis Treatment Market Size 2023-2028 ($ Millions)
    Figure 56. Middle East & Africa Vasculitis Treatment Market Size 2023-2028 ($ Millions)
    Figure 57. United States Vasculitis Treatment Market Size 2023-2028 ($ Millions)
    Figure 58. Canada Vasculitis Treatment Market Size 2023-2028 ($ Millions)
    Figure 59. Mexico Vasculitis Treatment Market Size 2023-2028 ($ Millions)
    Figure 60. Brazil Vasculitis Treatment Market Size 2023-2028 ($ Millions)
    Figure 61. China Vasculitis Treatment Market Size 2023-2028 ($ Millions)
    Figure 62. Japan Vasculitis Treatment Market Size 2023-2028 ($ Millions)
    Figure 63. Korea Vasculitis Treatment Market Size 2023-2028 ($ Millions)
    Figure 64. Southeast Asia Vasculitis Treatment Market Size 2023-2028 ($ Millions)
    Figure 65. India Vasculitis Treatment Market Size 2023-2028 ($ Millions)
    Figure 66. Australia Vasculitis Treatment Market Size 2023-2028 ($ Millions)
    Figure 67. Germany Vasculitis Treatment Market Size 2023-2028 ($ Millions)
    Figure 68. France Vasculitis Treatment Market Size 2023-2028 ($ Millions)
    Figure 69. UK Vasculitis Treatment Market Size 2023-2028 ($ Millions)
    Figure 70. Italy Vasculitis Treatment Market Size 2023-2028 ($ Millions)
    Figure 71. Russia Vasculitis Treatment Market Size 2023-2028 ($ Millions)
    Figure 72. Spain Vasculitis Treatment Market Size 2023-2028 ($ Millions)
    Figure 73. Egypt Vasculitis Treatment Market Size 2023-2028 ($ Millions)
    Figure 74. South Africa Vasculitis Treatment Market Size 2023-2028 ($ Millions)
    Figure 75. Israel Vasculitis Treatment Market Size 2023-2028 ($ Millions)
    Figure 76. Turkey Vasculitis Treatment Market Size 2023-2028 ($ Millions)
    Figure 77. GCC Countries Vasculitis Treatment Market Size 2023-2028 ($ Millions)

    Abbvie
    Ablynx
    Amgen
    Anthera Pharmaceuticals
    Aspen Pharmacare Holdings
    Astrazeneca
    Baxter
    Biogen
    Bristol-Myers Squibb
    Celgene
    Celltrion
    Chemocentryx
    Chugai Pharma Usa
    Eisai
    Eli Lilly
    F. Hoffmann-La Roche
    Genentech
    Gilead
    Glaxosmithkline
    Human Genome Sciences

LP Information presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

• Primary Source
  Players/Suppliers
  Industry Experts
  Distributors/Traders
  Opinion Leaders
  Front-line Staff
  Marketing Executives

  Secondary Source
  Journals and Periodicals
  Government Bodies
  Annual Reports
  Presentations
  Paid Databases
  LPI Internal Repository

• Data Synthesis
  Information Gathering
  Collation of Data
  Estimation of Key Figures
  Analysis of Derived Insights

  Data Validation
  Triangulation with Data Models
  Reference Against Proprietary
  Databases
  Corroboration with Industry Experts

• Qualitative Analysis
  Market drivers
  Market challenges
  Market trends
  Five forces analysis

  Qualitative Analysis
  Market size and forecast
  Market segmentation
  Geographical insights
  Competitive landscape